We could not find any results for:
Make sure your spelling is correct or try broadening your search.
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Top Brokers
Investor discussions surrounding British American Tobacco Plc (BATS) have revealed a mixed sentiment, closely tied to financial developments and market conditions. Key highlights include ongoing conversations about the company's substantial yield, strategic de-leveraging efforts, and the impact of recent legal challenges in Canada. Investors expressed optimism about the potential recovery in share price, with one commenter noting, “Being out makes no sense as the yield is so juicy and you never know when it may spike up.” Others pointed to upcoming corporate actions, including the anticipated demerger of ITC’s hotel business in early 2025, which could boost the company's cash position and aid in reducing net debt.
The financial outlook remains cautiously positive, despite concerns over profitability impacts from the Canadian market and debt levels. As one investor pointed out, net debt has seen a marginal decrease, indicating that the company is making progress in its de-leveraging strategy, with another stating, “We continue to make good progress on de-leveraging our balance sheet and expect to be within our narrowed leverage target range.” Overall, participants in the discussions showcased a mix of apprehension regarding external risks and a willingness to remain invested, highlighting the attractiveness of the current dividend yield amid ongoing corporate restructuring efforts.
Show more
British American Tobacco Plc (BAT) has been active with its share buyback program, purchasing significant quantities of its ordinary shares over several days in December 2024. Following the authority granted at the Annual General Meeting held on April 24, 2024, BAT executed multiple transactions with Merrill Lynch International, acquiring a total of 400,324 shares between December 13 and December 19, 2024. The highest price per share paid during these transactions fluctuated from 2,998 pence to 2,873 pence, with an average price around 2,887.5755 pence for the latest purchases.
Post these transactions and planned cancellations of the purchased shares, the company will have approximately 2.21 billion ordinary shares in circulation, excluding treasury shares. This buyback initiative reflects BAT's commitment to returning value to shareholders amid ongoing efforts to navigate the evolving landscape of the tobacco industry. Such buyback strategies are typically viewed as a positive signal by the market, suggesting confidence in the company's financial health and future prospects.
Show more
This has been an overhang for years, as it heads towards a resolution and clears the path for trading going forward, the net effects should be value adding over time once we know the costs.. |
18 October 2024 British American Tobacco p.l.c. ("BAT") |
Did not think I would say this Imps look better than Bats. |
Thinking of changing horses ie jumping g from IMPERIAL TO BATS.. |
Cheer up Salty and think of the divy !! |
IMB up again. BATS down again. This really is a trend! |
'Landlords look set to be exempt from Rachel Reeves’s capital gains tax (CGT) raid after Telegraph Money campaigned for Labour to end its war on property investors. |
Exponential population growth in the combustible tobacco markets of Indonesia, Malaysia and much of Africa probably pans. |
I would guess there has been a reduction in the western world but not in other parts such as South America / Asia and maybe the middle East. |
Interesting commentary from investors chronicle today in my inbox About so called sin stocks and in particular tobacco claiming that there were 500 million more smokers worldwide than in 1980 I was gobsmacked ! |
Bit disappointing, let's hope keeps above 2700p leading up to budget. |
There's a shed load of individual presentations on the company website. |
Any news what was said on Bats Capital Market Day, can't find any news. |
I also have similar weighting in both, but recently focused more in BATS due to their divi yield advantage. I see this as a good medium term income player with marginal upside on share price I plan to continue adding here GLA |
Use the dividends from 1 to fund the other, then you will have had them all for nothing and just keep building the position out for a year or 2, keep them both for 10 years and watch it play out.. |
Thank you. I think you are right. I need to think over the medium to long term. |
Paulstills - I haven’t done the comparison of the two to any great depth but feel that IMB longer term should do better due to its geographical revenue compared to BATS (more US focussed). Also don’t have as much faith in the non-combustible future profitability as the BATS management appears to have. Much prefer the revenue cash margin of sticks. |
I have been a holder of both for a number of years now. |
Yes I think you're right and wish I opted this strategy from the beginning rather than going only for BATS. Is it too late now to allocate some to IMB is what I'm thinking. |
Im 50:50 invested with IMB and BATS as they both appear to have runs together and at different times. Both generate a lot of cash so easier to just back both horses. |
I think I've backed the wrong horse. IMB going from strength to strength!! |
Inflation down which for us is good, but for companies, can't put up prices so much, or I'm I off track ? |
Not possible in 11 years ? |
The GBP will weaken as our interest rates come off their highs into 2025, BATS still own 25% of ITC and they are about to sell their non core hotel business and that windfall / special dividend payout will in turn fund our buybacks here for 2025/2026.. |
Let's hope it's not a case of better to travel than arrive, see what Mr Market makes of it tomorrow. |
Type | Ordinary Share |
Share ISIN | GB0002875804 |
Sector | Cigarettes |
Bid Price | 2,883.00 |
Offer Price | 2,885.00 |
Open | 2,889.00 |
Shares Traded | 586,421 |
Last Trade | 12:35:25 |
Low - High | 2,876.00 - 2,893.00 |
Turnover | 27.72B |
Profit | -14.37B |
EPS - Basic | -6.4870 |
PE Ratio | -4.44 |
Market Cap | 63.67B |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads